IP Library › Granted Patent US 11,680,111
Granted Patent B2
US 11,680,111 · App. 17/035,037 · Granted Jun 20, 2023

Method for separation of protein and other impurities from microbial capsular polysaccharides

Inventors: Ramesh Venkat Matur (Telangana, IN); Vivek Babu Kandimalla (Telangana, IN); Narender Dev Mantena (Telangana, IN); Mahima Datla (Telangana, IN); Muthyala Venkateswara Reddy (Telangana, IN); Kantam Charan (Telangana, IN)
C08B37/0003A61K39/092C12P19/04A61K39/00Y02A50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,680,111
App. No.
17/035,037
Granted
Jun 20, 2023
Kind
B2
Abstract

The invention relates to a method for the removal of protein and other impurities from microbial capsular polysaccharides. More particularly, the present invention relates to isolation of microbial capsular polysaccharides in pure form after removal of protein and other impurities.

Claims (8)

1. A method for preparing an immunogenic composition comprising a purified capsular polysaccharide conjugated to a carrier protein selected from the group consisting of diphtheria toxoid, tetanus toxoid, and CRM 197 , the method comprising:

exposing or contacting a solution of lysed Streptococcus pneumoniae cells comprising the capsular polysaccharide, proteins, nucleic acids, cell wall components and other impurities with silicone dioxide (SiO 2 );

separating the capsular polysaccharide from the SiO 2 by filtration or by centrifugation and without using chromatography to isolate the capsular polysaccharide in substantially pure form; and

conjugating the purified capsular polysaccharide to the carrier protein.

2. The method of claim 1 , wherein the Streptococcus pneumoniae comprises one or more serotypes selected from the group comprising of 1, 2, 3, 4, 5, 6A, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F, and 33F.

3. The method of claim 1 , wherein the SiO 2 comprises particles each having a size ranging from 0.01 μm to 200 μm.

4. The method of claim 1 , wherein the solution of lysed cells is exposed or contacted with the SiO 2 at a temperature ranging from 15° C. to 60° C. for a period of time ranging from 10 minutes to 16 hours.

5. The method of claim 1 , wherein the SiO 2 is in an amount ranging from 0.5% to 20% weight/volume (w/v).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 28, 2020
From: MATUR, RAMESH VENKAT; KANDIMALLA, VIVEK BABU; MANTENA, NARENDER DEV; DATLA, MAHIMA; REDDY, MUTHYALA VENKATESWARA; CHARAN, KANTAM
To: BIOLOGICAL E LIMITED
Reel/Frame 053907/0141 →
Priority Claims (1)
IN 2161/CHE/2015 · Apr 28, 2015 · national
Continuity (2)
Division 15568558
Related Publication 20210017300A1 · Jan 21, 2021